Apr 15, 2021 / 03:45PM GMT
Joseph Robert Stringer - Needham & Company, LLC, Research Division - Associate
Good morning, everyone. Thank you for joining the 20th Annual Needham Healthcare Conference. My name is Joey Stringer, and I'm one of the biotech analysts at Needham & Company. It's my pleasure to introduce our next company, Moderna. Joining us today from Moderna are CFO, David Meline; and SVP, Investor Relations, Lavina Talukdar. We'll begin with a brief overview, company overview, followed by a fireside chat section. But for those of you participating on the webcast, if you want to submit a question, you can do so at any time. And you can do that by using the chat box feature in the web browser.
So with that, we'll get started. And I'll turn it over to David.
David W. Meline - Moderna, Inc. - CFO & Principal Accounting Officer
Okay. Well, thank you very much for joining today. I reflect sometimes about a year ago when I joined the company, most people I told didn't, they didn't recognize the name of the company. Whereas today, when you tell people about Moderna,
Moderna Inc at Needham Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot